Jiangsu Aidea Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 688488.SS

Jiangsu Aidea Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2023: USD -1.64 M

Jiangsu Aidea Pharmaceutical Co., Ltd. Dividends Paid is USD -1.64 M for the year ending December 31, 2023, a -226.94% change year over year. Dividends paid is cash paid to shareholders as a distribution of profits.

Jiangsu Aidea Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2022 was USD -502.13 K, a 84.17% change year over year.
Jiangsu Aidea Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2021 was USD -3.17 M, a -562.76% change year over year.
Jiangsu Aidea Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2020 was USD -478.72 K, a 40.47% change year over year.
Jiangsu Aidea Pharmaceutical Co., Ltd. Dividends Paid for the year ending December 31, 2019 was USD -804.17 K, a -72.92% change year over year.

Key data

Date	Dividends Paid	Capital Expenditure	Other Financing Activities	Net Cash Used Provided By Financing Activities

Shanghai Stock Exchange: 688488.SS

Jiangsu Aidea Pharmaceutical Co., Ltd.

CEO	Mr. Jie Zhang
IPO Date	July 20, 2020
Location	China
Headquarters	No. 2 Liuzhuang Road
Employees	476
Sector	Health Care
Industries Pharmaceuticals Cosmetics

Description

Jiangsu Aidea Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. It offers folium sennae granules, powdered bacillus tablets, clindamycin hydrochloride capsules, sodium bicarbonate tablets, nitrendipine tablets, metronidazole tablets, compound gentamycin sulfate and procaine hydrochloride sulfate granules, and cefradine capsules, as well as raw materials. The company was founded in 2009 and is based in Yangzhou, China.

Key trends

Past 5 years